Breast cancer remains one of the most common cancers affecting women worldwide. Understanding its progression is crucial for developing effective treatments. One key process involved in tumor growth is angiogenesis, the formation of new blood vessels from existing ones.

What Is Angiogenesis?

Angiogenesis is a normal biological process that occurs during growth and wound healing. However, in cancer, this process is hijacked to supply the tumor with nutrients and oxygen, facilitating its growth and potential to spread.

The Role of Angiogenesis in Breast Cancer

In breast cancer, tumors release signals that stimulate nearby blood vessels to grow toward them. This process is driven by various factors, including vascular endothelial growth factor (VEGF). As new vessels form, they provide the tumor with the resources needed for rapid growth and metastasis.

Key Factors Promoting Angiogenesis

  • VEGF: The primary driver of new blood vessel formation in tumors.
  • FGF (Fibroblast Growth Factor): Supports the proliferation of endothelial cells.
  • Hypoxia: Low oxygen levels in tumors trigger the release of angiogenic factors.

Implications for Treatment

Targeting angiogenesis is a promising strategy in breast cancer therapy. Anti-angiogenic drugs aim to inhibit blood vessel formation, starving the tumor of nutrients. Examples include bevacizumab, which blocks VEGF activity.

Current Challenges

  • Resistance to anti-angiogenic therapy over time.
  • Side effects related to blood vessel inhibition.
  • Identifying patients who will benefit most from these treatments.

Research continues to improve these therapies, aiming for more effective and personalized treatment options for breast cancer patients.